Last10K.com

American Cryostem Corp (CRYO) SEC Filing 10-Q Quarterly report for the period ending Monday, December 31, 2018

American Cryostem Corp

CIK: 1468679 Ticker: CRYO
Document and Entity Information - shares
3 Months Ended
Dec. 31, 2018
Feb. 15, 2019
Document and Entity Information:  
Entity Registrant NameAMERICAN CRYOSTEM Corp 
Document Type10-Q 
Document Period End DateDec. 31, 2018 
Amendment Flagfalse 
Entity Central Index Key0001468679 
Current Fiscal Year End Date--09-30 
Entity Common Stock, Shares Outstanding 48,854,043
Entity Filer CategoryNon-accelerated Filer 
Entity Emerging Growth Companyfalse 
Entity Small Businesstrue 
Entity Current Reporting StatusYes 
Document Fiscal Year Focus2019 
Document Fiscal Period FocusQ1 

View differences made from one quarter to another to evaluate American Cryostem Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Cryostem Corp.

Continue

Assess how American Cryostem Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Cryostem Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Balance Sheets
Balance Sheets (Parenthetical)
Statements Of Cash Flows
Statements Of Changes In Shareholder's Deficit
Statements Of Operations
1. Organization Of The Company And Principles Of Consolidation And Summary Of Accounting Policies
1. Organization Of The Company And Principles Of Consolidation And Summary Of Accounting Policiess (Policies)
1. Organization Of The Company And Significant Accounting Policies (Details Narrative)
1. Organization Of The Company And Significant Accounting Policies (Details)
1. Organization Of The Company And Significant Accounting Policies (Tables)
10. Commitment &Amp; Contingencies
10. Commitments &Amp; Contingencies (Details 1)
10. Commitments &Amp; Contingencies (Details Narrative)
10. Commitments &Amp; Contingencies (Details)
10. Commitments &Amp; Contingencies (Tables)
11. Concentrations Of Credit
12. Investments
13. Related Party Transactions
13. Related Party Transactions (Details Narrative)
14. Non-Cash Transactions
15. Subsequent Events
2. Going Concern
3. Loss Per Share
3. Loss Per Share (Details Narrative)
3. Loss Per Share (Details)
3. Loss Per Share (Tables)
4. Fixed Assets
4. Fixed Assets (Details Narrative)
4. Fixed Assets (Details)
4. Fixed Assets (Tables)
5. Patent &Amp; Patents Filings (Details Narrative)
5. Patents &Amp; Patents Filings
6. Debt
6. Debt (Details)
6. Debt (Tables)
7. Common Stock Issuances
8. Option Issuances
8. Option Issuances (Details)
8. Option Issuances (Tables)
9. Fair Values Of Financial Instruments

Material Contracts, Statements, Certifications & more

American Cryostem Corp provided additional information to their SEC Filing as exhibits

Ticker: CRYO
CIK: 1468679
Form Type: 10-Q Quarterly Report
Accession Number: 0001019056-19-000161
Submitted to the SEC: Tue Feb 19 2019 1:28:08 PM EST
Accepted by the SEC: Tue Feb 19 2019
Period: Monday, December 31, 2018
Industry: Health And Allied

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cryo/0001019056-19-000161.htm